Poly Medicure Limited (POLYMED) fair value: what the stock is really worth
As of Nov 16, 2026: fair value (intrinsic value) of Poly Medicure Limited stock ₹1,052, price ₹1,684, that is 37.5% below the price, quality 43 out of 100. Rating: strongly overvalued. Calculated from audited financials with 16 of our 26 valuation models and 37 quality factors, updated daily.
- Keep an eye on it?Free in your watchlist: 5 stocks without an account, 10 with one Yes, for free
Poly Medicure Limited
POLYMED · NSEFar too expensive (fair value 38% below the price), weak company and falling price: meets none of the 3 rules.
What runs behind every stock
69 individual criteria per stock, every one traceable See the method →
Price vs Fair Value
White line = price, green steps = our fair value per fiscal year. As of Nov 12, 2026.
How to read this chart
60‑month range ₹661.21 – ₹3,117 · fair‑value band ₹777.56 – ₹1,327 · the ₹1,684 price screens above the ₹1,052 fair value. As of Nov 12, 2026.
Every Wednesday you see whether Poly Medicure is on track or worth a review, plus price against fair value. Free, up to 3 stocks.
We send you a confirmation link. Unsubscribe with one click.
Company profile
Poly Medicure Limited engages in the manufacture and sale of medical devices in India and internationally.
Show moreShow less
The company offers infusion therapy products, such as I.V Infusion set, extension lines, needle free connector, I.V flow regulator extension set, burette set, three way stop cock, vial access spike, transfer spike, orburator, polyflush, maifolds, polyswab, and arterial blood collection; critical care products, including vial access spikes, arterial cannula, mini mid lines over the wire, extension line, enteral connector, central venous catheters, and huber needle; dialysis and renal care products, comprising peritoneal dialysis set, haemocent, standard and safety fistula needle, dialyzer, bloodlines and dialysis system.
It also provides cardiology products PTFE wire, inflation device, Y-connector, manifold, introducer, IV Cannula, hydrophilic wire, guiding catheter, drug eluting stent, PTCA dilation catheter, diagnostic catheter, and electrocardiograph electrodes; vaccular access products; oncology products; diagnostics products, such as blood collection tubes, safety blood collection set, blood collection needles, and standard needle holder.
In addition, the company offers transfusion system products, including blood bags, blood administration set, and others; anesthesia and respiratory care products, comprising variable concentration masks, oxygen mask with reservoirs, fixed concentration masks, aerosol therapy masks, ventilator circuits, suction catheters, spinal needle, polyciser, oxygen catheter, nebulizer compressor system, twin bore nasal oxygen cannula mucus extractor, HME filter, oro-pharyngeal airways, endotracheal tubes, catheter mount, and brain circuit; urology products, including urine collection bags, leg bag set, irrigation sets, foley balloon and urine drainage catheters, and urine collection bags with measured volume meters; wound drainage; and gastroenterology products.
The company was incorporated in 1995 and is based in New Delhi, India.
Stock analysis
Poly Medicure Limited (POLYMED) currently trades at ₹1,684, while our model-based Fair Value estimate is ₹1,052, 38% below the price, so the stock looks overvalued today.
Show more
Valuation
Bull case: the Growth Earnings group reads highest at a median of ₹808.03 per share, and 0 of the 16 models we run sit above the ₹1,684 price.
Bear case: the Asset-Based group reads lowest at ₹111.42, and 16 of the 16 models stay below the price. Data coverage for this calculation is medium.
Scenario range: ₹777.56 (bear) to ₹1,327 (bull), the price of ₹1,684 sits above it. Bear and bull are the same models on cautious and optimistic assumptions, a range, not a price target.
Quality & growth
The Quality Score stands at 43/100 (below-average quality), in the Healthcare sector.
Expensive Growth: The company is growing, but growth may require heavy reinvestment or weak cash conversion.
Poly Medicure Limited reported revenue of ₹18.8B in FY2026 versus ₹9.2B in FY2022, a compound +19.4%/yr. Reported net income was ₹3.2B in FY2026, compounding +21.8%/yr from FY2022.
Key figures
Market cap ₹171B (≈ $1.8B) Small · P/E ratio 53.7 · P/S ratio 8.01 · EPS (TTM) ₹31.37 · Dividend yield 0.2% · Net margin 14.9% · Return on equity 10.1% · Return on assets (EBIT) 24.9% (5-year average).
Competitive moat
Our AI-assisted moat analysis scores the competitive advantage at 58 out of 100 (low confidence).
What moves the price
The share trades about 14% below its 52-week high and 42% above its 52-week low, currently above its 200-day average.
For context, the median of 10 Healthcare peers we cover trades at −44% fair-value upside, at −38%, POLYMED screens cheaper than that median.
Fair Value models
All 16 models by family
The fair value above starts from this blend and is adjusted for a year distorted by one-off effects.
Quality Score breakdown
It rates the business: profits, how they develop, real cash, balance sheet, investing and share count.
Revenue & earnings trend
POLYMED screens overvalued: fair value 38% below the price. Compare with Intuitive Surgical, Inc →
Compare Poly Medicure Limited with another stock
Price, fair value, quality and upside side by side.
Peer GroupⓘHow this stock ranks against its industry: the green marker is this stock, the band is the typical 25–75% peer range, and the tick is the median.Medical Instruments & Supplies · 199 stocks
Valuation Multiplesvs Medical Instruments & Supplies median · lower = cheaper
Strength profile in five axes (Snowflake)
VALUE 0: the price sits above our fair-value range.
Context: sector, industry, market
- Is the Health Care sector expensive or cheap?
- P/E, EV/EBITDA and margins by industry (reference tables)
- Return on equity by industry
- Quality Score by industry
- Piotroski F-Score screener with fair value
- Undervalued stocks: Indian Stocks
- Valuation of the India market
Values & ESG
Does this company touch areas you may want to avoid? The classification is inferred from sector and industry.
Similar stocks
10 more Medical Instruments & Supplies stocks, each showing price versus our Fair Value estimate.
| Stock | Price | Fair Value | vs Fair Value | Compare |
|---|---|---|---|---|
| Solventum Corporation SOLV | $89.08 | $131.27 | +47% | vs POLYMED |
| EssilorLuxottica Société anonyme EL | €184.50 | €196.22 | +6% | vs POLYMED |
| Intuitive Surgical, Inc ISRG | $443.59 | $353.90 | −20% | vs POLYMED |
| Medline Inc MDLN | $39.47 | $28.59 | −28% | vs POLYMED |
| Alcon Inc ALC | CHF 62.14 | CHF 35.08 | −44% | vs POLYMED |
| Becton, Dickinson and Company BDX | $218.03 | $97.80 | −55% | vs POLYMED |
| Straumann Holding STMN | CHF 108.75 | CHF 45.50 | −58% | vs POLYMED |
| West Pharmaceutical Services, Inc WST | $416.42 | $139.22 | −67% | vs POLYMED |
| Sartorius Stedim Biotech S.A DIM | €225.20 | €54.82 | −76% | vs POLYMED |
| Sartorius Aktiengesellschaft SRT | €226.50 | €46.44 | −80% | vs POLYMED |
Explore undervalued stocks
More undervalued Healthcare stocks →
Try a ready-made strategy
Pick a strategy and jump into the live analysis with that exact screen applied.
Discover tools
Frequently asked questions
Is Poly Medicure Limited (POLYMED) overvalued or undervalued?
What is the fair value of POLYMED?
What is the quality score of POLYMED?
What is the price target for Poly Medicure Limited (POLYMED)?
What is the Poly Medicure Limited stock forecast for 2026?
What is the revenue of Poly Medicure Limited (POLYMED)?
Does Poly Medicure Limited pay a dividend?
How much is the dividend of Poly Medicure Limited (POLYMED) and when is the ex-dividend date?
What is the intrinsic value of Poly Medicure Limited (POLYMED)?
Is Poly Medicure Limited stock overvalued or undervalued in 2026?
Is fair value the same as the market price of POLYMED?
How much is Poly Medicure Limited worth?
What do the bullish and bearish scenarios say about POLYMED?
What is the P/E ratio of POLYMED?
How solid is the balance sheet of Poly Medicure Limited (POLYMED)?
How far is POLYMED from its 52-week high?
Which stocks are comparable to Poly Medicure Limited?
Is Poly Medicure Limited stock attractive at the current price?
How is the fair value of POLYMED calculated?
Is it still worth investing in stocks now?
What is the share price of Poly Medicure Limited (POLYMED)?
What should I pay attention to with Poly Medicure Limited right now?
Where does the earnings growth of Poly Medicure Limited (POLYMED) come from?
Key figures of Poly Medicure Limited
How large is the market capitalisation of Poly Medicure Limited (POLYMED)?
What is the P/S ratio of Poly Medicure Limited (POLYMED)?
What are the earnings per share of Poly Medicure Limited (POLYMED)?
What is the dividend yield of Poly Medicure Limited (POLYMED)?
What is the net margin of Poly Medicure Limited (POLYMED)?
What is the return on equity of Poly Medicure Limited (POLYMED)?
What is the EBIT return on assets of Poly Medicure Limited (POLYMED)?
What is the operating margin of Poly Medicure Limited (POLYMED)?
How fast is revenue growing at Poly Medicure Limited (POLYMED)?
How fast are earnings growing at Poly Medicure Limited (POLYMED)?
How much free cash flow does Poly Medicure Limited (POLYMED) generate?
How much net debt does Poly Medicure Limited (POLYMED) carry?
Watch Poly Medicure Limited in the live analysis
One click puts Poly Medicure Limited on your watchlist: fair value and trend at a glance, plus comparison, the diversification check and the 27,000+ stock screener.
Watch for free →Zero risk: nothing is ever charged. Your watchlist is yours, with or without an account.